Biotech Investors & VC Firms in North America
1593 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.
Pier 70 Ventures
SeattleSeed–Series A
17 people
Fine Structures Ventures
CambridgePre-Seed–Late Stage
10 people
Barrel Ventures
EvanstonSeed
6 people
Blue Bear Ventures
BerkeleyPre-Seed–Series A$100K – $400K
6 people
Seed Round Capital
HoustonPre-Seed–Seed$50K – $250K
12 people
Triatomic Capital
Palo AltoSeed–Series C$100K – $1M
9 people
Animal Capital
RaleighPre-Seed–Series B$100K – $1M
8 people
Sycamore Ventures
PrincetonGrowth–Late Stage$5M – $20M
14 people
Partnership Fund for NYC
New York CitySeries A–Growth
10 people
Ballast Point Ventures
TampaGrowth$5M – $15M
12 people
Latterell Venture Partners
San RamonSeed–Series A$50K – $10M
6 people
Plains Ventures
Oklahoma CitySeed–Series A$250K – $1M
3 people
Clarevia Ventures
MadisonSeed–Series A$250K – $2.5M
11 people
Easton Capital
New YorkSeed–Late Stage$10M – $20M
7 people
Salveo Capital
NorthbrookSeed–Growth
10 people
SigmaBleyzer
HoustonGrowth$5.4M – $54M
13 people
Black Flag
San DiegoPre-Seed–Seed$500K – $5M
6 people
CU Healthcare Innovation Fund
AuroraSeed–Series A
6 people
Solasta Ventures
BostonSeed–Series B
6 people
Cerberus Ventures
New YorkSeed–Series A
11 people
Cross-Border Impact Ventures
TorontoSeries A–Series B$2M – $10M
11 people
Harbor Light Capital Partners
KeeneSeed–Series A$1M – $5M
8 people
Luma Group
New YorkSeed–Growth
14 people
Ev3 Ventures Llc
New YorkPre-Seed–Seed$500K – $3M
2 people
Related lists
Investors & VC Firms in North America (13518)Investors & VC Firms in United States (12555)Investors & VC Firms in Europe (5846)Investors & VC Firms in Global (4720)AI & Machine Learning Investors & VC Firms (4549)Fintech Investors & VC Firms (4537)SaaS Investors & VC Firms (4215)Healthtech Investors & VC Firms (4185)Enterprise Software Investors & VC Firms (4097)Crypto & Web3 Investors & VC Firms (3965)
Data sourced from public filings and firms' own websites — see our methodology.

































































































